How to Import Mylotarg (gemtuzumab ozogamicin) in India Under Named Patient Program

Mylotarg is a CD33-directed antibody-drug conjugate indicated for the treatment of newly-diagnosed CD33-positive acute myeloid leukemia (AML) in…

May 5, 2026
CAR-T vs Monjuvi: A Battle of Complexity vs Accessibility

Despite being precision based targeted therapies, Chimeric Antigen Receptor T-Cell therapy (CAR-T) and Monjuvi (tafasitamab-cxix) perform differently across…

April 30, 2026
Why Availability of Blincyto Takes Time: The Behind-the-Scenes Journey of Importing Speciality Medicines

Blincyto (blinatumomab) is a bispecific CD19-directed CD3 T-cell used in the treatment of certain types of Acute Lymphoblastic…

April 28, 2026
How to Prepare Your Body & Mind Before Starting Talvey

It feels overwhelming to get diagnosed with cancer and to start the treatment immediately, especially for patients exploring…

April 18, 2026
Roadmap to check a Licensed Importer for Itovebi Access

While the production of innovative drugs like Itovebi (Inavolisib) is limited and the demand for Itovebi is high,…

April 6, 2026
Managing Side Effects on Ayvakit: Expert Tips & Clinical Insights

Ayvakit (avapritinib) is a kinase inhibitor that blocks abnormal signalling and stops cancer cell growth that is used…

March 18, 2026
Step-by-Step: What Happens Inside the Body During a Columvi Infusion?

Many patients are curious to know about Columvi treatment which is a type of immunotherapy (causes the body’s…

February 2, 2026
Columvi (Glofitamab) in India: Mechanism, Safety & Access Checklist

Columvi is a drug used for cancer patients suffering from diffuse large B-cell lymphoma DLBCL), a cancer involving…

November 12, 2025
Glofitamab in India: Cost, Import Process & How to Obtain Safely

COLUMVI (glofitamab-gxbm) is an innovative prescription medicine approved for the treatment of adults with relapsed or refractory diffuse…

October 1, 2025